The Pharmacology Center

Filter Your Results

 

News

 

Study Evaluates Risks and Benefits of Prolonged DAPT After Stenting in Women

August 13, 2018 -- An analysis of the benefits and risks of prolonged dual antiplatelet therapy (DAPT) after coronary stenting in women was conducted by the DAPT study investi…

Medicure Launches Zypitamag Statin in the United States

May 15, 2018 -- Medicure Inc. recently announced that its Zypitamag (pitavastatin magnesium) tablets are now available in the United States, where they are sold through the co…

Elective Coronary Revascularization Procedures Evaluated in Patients With Stable CAD

May 14, 2018 -- Findings from a study describing the incidence, determinants, and outcomes of elective coronary revascularization (ECR) in patients with stable coronary artery…

FDA Approves Portola Pharmaceuticals’ Andexxa for the Reversal of Factor Xa

May 14, 2018 -- Portola Pharmaceuticals, Inc. recently announced that the US Food and Drug Administration (FDA) has approved the company's Andexxa (coagulation factor Xa […

Analysis From ACCELERATE Trial Evaluates ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease

March 12, 2018 -- Steven E. Nissen, MD, presented findings from an analysis of the ACCELERATE trial of ADCY9 genetic variants and cardiovascular outcome with evacetrapib in a …

SMART-DATE Trial Shows Increased Risk of Heart Attack With Short-Term DAPT in ACS Patients

March 12, 2018 -- The SMART-DATE trial was presented by Principal Investigator Hyeon Cheol Gwon, MD, in a Late Breaking Trial session at the American College of Cardiology'…

PHARMCLO Evaluates Genetic Screening to Inform the Selection of Antiplatelet Drugs in ACS Patients

March 11, 2018 -- The PHARMCLO trial demonstrated that patients with acute coronary syndrome (ACS) experienced a substantially lower rate of heart attack, stroke, death from c…

ARTEMIS Investigates If Reducing Copayments Could Improve Adherence to Medication Therapy After Heart Attacks

March 11, 2018 -- Findings from the ARTEMIS study were presented by Tracy Wang, MD, in a Late Breaking Trial session at the American College of Cardiology's (ACC) 67th ann…

 

advertisement

2019 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 

Top 5 Top 5 In Pharmacology Center

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

Abbott Vascular's XIENCE 28 GLOBAL Trial Enrolls First Patient in Europe

SMART-DATE Trial Shows Increased Risk of Heart Attack With Short-Term DAPT in ACS Patients

Alirocumab PCSK9 Inhibitor Studied in ODYSSEY Outcomes Trial of ACS Patients

One-Year Outcomes From PRAGUE-18 Trial Compare Prasugrel and Ticagrelor

 

Centers

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

Other Resources

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.